The proposed research concentrates on three aspects of axonal regeneration in the nervous system. The first specific aim addresses the investigator's hypothesis that the repellent Sema3A might interfere with the regeneration of peripheral sensory and motor axons were it not for the presence of Sema3B and Sema3C in the peripheral nerve. He proposes that these two related semaphorins directly antagonize Sema3A repellent activity by competing for a receptor component, neuropilin-1. Sema3B or C would be overexpressed in transgenic mice either in Schwann cells using the P0 promoter or in epidermal cells using a keratin promoter. Alternatively, a soluble form of NP-2 that should bind and inactivate Sema3B and C, but not A, could be expressed in the same way. If overexpression of Sema3B or C increases regeneration, and overexpression of soluble NP-2 decreases regeneration, the hypothesis would be supported. The second specific aim is directed towards an analysis of the molecule recently purified by the Schwab group, NI250, which is purported to be a general inhibitor of regeneration in the CNS. The Schwab group published microsequence data from the protein they have spent the last 10 years characterizing and the investigator has used this information to identify a full-length EST clone. Preliminary studies suggest that a recombinant version of the very small extracellular portion of this protein can inhibit axon outgrowth. The investigator proposes to determine where NI250 is expressed, to see if any of the proteins most related to NI250 have similar outgrowth inhibiting activities, to define those portions and residues within the extracellular moiety that are required for inhibitory activity, and to generate an alkaline phosphatase (AP)-tagged version of this extracellular moiety to search for a receptor. Finally, the investigator has identified 5 stem cell lines in the Omnibank database in which the NI250 gene is likely to be disrupted. He proposes to analyze the resulting KO mice for normal myelin function and their capacity for regeneration. If the mice develop normally, and if NI250 is a major impediment to regeneration in the CNS, then regeneration may be improved in the KO mice. The third specific aim is focused on the further characterization of three molecules that have been identified with microarray techniques to be upregulated after crushing the sciatic nerve, and which may therefore be associated with regenerative events. It is proposed to further characterize their normal distributions and regulation during regeneration, and to determine if their overexpression (with a herpes virus expression system) in cultured DRG or retinal neurons affects various parameters of axon outgrowth. Similar assays will be performed while reducing the expression of these proteins in cultured cells with trituration-loaded antibodies or antisense oligonucleotides.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
3R01NS039962-01S1
Application #
6348863
Study Section
Special Emphasis Panel (ZRG1 (03))
Program Officer
Chiu, Arlene Y
Project Start
2000-04-01
Project End
2005-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
1
Fiscal Year
2000
Total Cost
$50,000
Indirect Cost
Name
Yale University
Department
Neurology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Shim, Sang-Ohk; Cafferty, William B J; Schmidt, Eric C et al. (2012) PlexinA2 limits recovery from corticospinal axotomy by mediating oligodendrocyte-derived Sema6A growth inhibition. Mol Cell Neurosci 50:193-200
Akbik, Feras; Cafferty, William B J; Strittmatter, Stephen M (2012) Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity. Exp Neurol 235:43-52
Wang, Xingxing; Duffy, Philip; McGee, Aaron W et al. (2011) Recovery from chronic spinal cord contusion after Nogo receptor intervention. Ann Neurol 70:805-21
Huebner, Eric A; Kim, Byung G; Duffy, Philip J et al. (2011) A multi-domain fragment of Nogo-A protein is a potent inhibitor of cortical axon regeneration via Nogo receptor 1. J Biol Chem 286:18026-36
Zai, Laila; Ferrari, Christina; Dice, Carlie et al. (2011) Inosine augments the effects of a Nogo receptor blocker and of environmental enrichment to restore skilled forelimb use after stroke. J Neurosci 31:5977-88
Cafferty, William B J; Duffy, Philip; Huebner, Eric et al. (2010) MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci 30:6825-37
Hånell, Anders; Clausen, Fredrik; Björk, Maria et al. (2010) Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice. J Neurotrauma 27:1297-309
Harel, Noam Y; Song, Kang-Ho; Tang, Xin et al. (2010) Nogo receptor deletion and multimodal exercise improve distinct aspects of recovery in cervical spinal cord injury. J Neurotrauma 27:2055-66
Gunther, Erik C; Strittmatter, Stephen M (2010) Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease. J Mol Med (Berl) 88:331-8
Gimbel, David A; Nygaard, Haakon B; Coffey, Erin E et al. (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 30:6367-74

Showing the most recent 10 out of 48 publications